DVA

DaVita Inc. (DVA)
Healthcare • Medical Care Facilities • $183.99 • MCap: 11,738,562,560 🌐
https://www.davita.com • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Buy Decision Core
Total Score
65
Business Quality
11
Financial Strength
10
Growth Outlook
15
Momentum
3
Price Action
Current
183.99
52W High
240.96
52W Low
103.87
Above 50DMA
208.28 (-11.66%)
Above 200DMA
164.08 (12.13%)
Relative Strength
Relative Strength
0.21
RS 3M
-0.04
RS 6M
0.22
RS 9M
0.56
RS 12M
0.35
Fundamentals
Revenue Growth
0.05%
Earnings Growth
0.56%
ROE
0.88%
ROA
0.08%
Valuation
PE (Fwd)
10.67
PEG
0.44
P/B
-15.38
Upside
18.72%
Risk
Beta
0.83
Short %
0.12
Risk Score
2.00
Analyst
Rating
buy
Target
218.43
Beta
0.83
Analysts
0


Total Score
65
Upside
18.72%
Relative Strength
0.21
Beta
0.83
Why Buy?
  • PEG Ratio below 1 (attractive valuation)
  • Trading below book value
  • Trading above 200 DMA
  • Analyst upside exceeds 15%
Key Risks
Score Breakdown
Business
11
Financial
10
Growth
15
Valuation
17
Risk
3
Momentum
3
Technical
52W High: 240.96
52W Low: 103.87
Above 50DMA: -11.66%
Above 200DMA: 12.13%
Valuation
Forward PE: 10.67
PEG: 0.44
P/B: -15.38
Upside: 18.72%
Risk
Beta: 0.83
Short Float: 0.12%
ROE: 0.88%
ROA: 0.08%